Cladribine

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
Lars
Family Elder
Posts: 433
Joined: Wed Mar 21, 2007 3:00 pm
Location: Durango, Co
Contact:

Cladribine

Post by Lars »

As I continue to hear of Cladribine's push towards approval, it occurred to me that I haven't really heard a lot of discussion here about it. Has anyone taken part in the trials? The data seems impressive to this point.
Thanks,
Lars
User avatar
fashion-bunny
Newbie
Posts: 1
Joined: Tue Jan 26, 2010 3:00 pm
Contact:

hi

Post by fashion-bunny »

There are many Trial of Oral Cladribine one such report by Merck Serono shows 58% reduction in annualized relapse rates with the low dose and a 55% reduction with the high dose at 2 years.
Womens Spa Robes - Womens Organic Spa Robes<div><div>
User avatar
ms2009
Family Member
Posts: 44
Joined: Sat Jan 16, 2010 3:00 pm

Post by ms2009 »

Any side effects or symptoms please?
User avatar
burntsienna
Family Member
Posts: 35
Joined: Tue Feb 20, 2007 3:00 pm
Location: wales, UK
Contact:

cladribine in the uk

Post by burntsienna »

They're already applying for a license here in the UK. Which means it could be available by 2011 in the UK. However, I'm really not sure I like the idea of increasing my risk of getting cancer or life threatening infections (the guardian article has more about this)!

In brief:
http://news.bbc.co.uk/1/hi/health/8470138.stm

A bit more detailed (Guardian Article):
<shortened url>
Post Reply

Return to “Mavenclad (Cladribine)”